$19.90
-4.5%Nature's Sunshine Products, Inc., a natural health and wellness company, primarily manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. The company also provides immunity, cardiovascular, and digestive products; and personal care products, such as oils and lotions, aloe vera gels, herbal shampoos, herbal skin treatment, toothpaste, and skin cleansers, as well as weight management products. It offers its products under the Nature's Sunshine and Synergy WorldWide brands through a sales force of independent consultants. The company was founded in 1972 and is headquartered in Lehi, Utah.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.
NATR • NASDAQ
| Nature's Sunshine Products, Inc. Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | Dec 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OPERATING ACTIVITIES | ||||||||||||||||||||
0.0 | 7.9M | 15.1M | 550K | 30.2M | 23M | 6.9M | -1.2M | -13.8M | 675K | 13.7M | 9.8M | 17.6M | 25.4M | 17.6M | -1.2M | 6.1M | -1.8M | -8.2M | -3.6M | |
0.0 | 14.2M | 11.8M | 11M | 11.2M | 10.7M | 10.6M | 9.8M | 8.6M | 4.8M | 4.5M | 4.4M | 4.5M | 4.1M | 4.4M | 4.3M | 4.5M | 5.4M | -6.4M | -6.2M | |
0.0 | -1.7M | -8.5M | 6.6M | -4.1M | -4.4M | 4.3M | -18K | 14.1M | 766K | -3.4M | -3.9M | 1.1M | 4.3M | -5.1M | 2.1M | -4M | -3.1M | -1.5M | -2.7M | |
0.0 | 4.8M | 4.9M | 2.9M | 3.7M | 3.8M | 2.1M | 2.2M | 2.2M | 3.2M | 4.5M | 3.9M | 3.4M | 2.9M | 3.5M | 437K | 478K | 86K | 326K | 0.0 | |
38.4M | 8.5M | 4.8M | 7M | 8.4M | 3.7M | 6.3M | -778K | -1.9M | 1.7M | -1.2M | 6.7M | -1.2M | -357K | -74K | 6.8M | -1.1M | 3.6M | 14.2M | 14.1M | |
(12.5M) | (14.8M) | (9.3M) | (5.6M) | (202K) | (4.8M) | (6.9M) | (3.5M) | (4.6M) | (3.6M) | (9.8M) | (6.5M) | (10.3M) | (13M) | (6.6M) | (5.6M) | (8.4M) | (5.8M) | (11.1M) | (6M) | |
-3.1M | -8.5M | 13.2M | -27.3M | -14.7M | 793K | -21.7M | 11.9M | 1.3M | -7.7M | -7.9M | -6.7M | 4M | -9.6M | -16.4M | 3.8M | -5.1M | -3.4M | 14.5M | 12.8M | |
35.3M | 25.3M | 41.2M | 710K | 34.6M | 37.7M | 8.5M | 21.8M | 10.5M | 3.4M | 10.2M | 14.2M | 29.4M | 26.7M | 3.9M | 16.2M | 927K | 772K | 12.8M | 14.3M | |
INVESTING ACTIVITIES | ||||||||||||||||||||
-6.5M | -11M | -10.5M | -7.6M | -6.7M | -4.9M | -5.1M | -4.8M | -5.5M | -11.5M | -22.5M | -26.3M | -8.6M | -6.6M | -2.4M | -2.6M | -3.2M | -7.5M | -5.5M | -3.5M | |
-6.2M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (2K) | (5M) | (521K) | (0.0) | (3.1M) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (763K) | |
(0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -3K | -721K | -442K | -174K | -7M | -3.4M | (0.0) | (0.0) | (0.0) | -1.9M | |
0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.8M | 5K | 810K | 247K | 200K | 3.8M | 7.7M | 125K | 2.8M | 665K | 1.4M | 1.4M | |
0.0 | 0.0 | 0.0 | 0.0 | 54K | 0.0 | 2K | 5M | 521K | -504K | 3.1M | 85K | 248K | 25K | 11K | 0.0 | 70K | 80K | -1.7M | -736K | |
-12.6M | -11M | -10.5M | -7.6M | -6.6M | -4.9M | -5.1M | (211K) | -3.2M | -11.5M | -18.6M | -26.7M | -8.6M | -3M | -1.7M | -5.9M | -297K | -6.8M | -5.7M | -4M | |
FINANCING ACTIVITIES | ||||||||||||||||||||
-16.3M | -8.9M | -6.4M | -13.6M | -7.4M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -6.6M | -7.5M | -2.5M | 2.4M | 0.0 | 0.0 | 0.0 | 0.0 | 1.3M | 0.0 | |
0.0 | 0.0 | -1.2M | -1.5M | -2.2M | 3.4M | 0.0 | -12.2M | 3.8M | 7.2M | 0.0 | -12.3M | 6.6M | -3.6M | 9.2M | 0.0 | 0.0 | 0.0 | 0.0 | -7M | |
(0.0) | (0.0) | (0.0) | (0.0) | -19.9M | (0.0) | (0.0) | (0.0) | -1.8M | -7.5M | -7.5M | -35.2M | -30.4M | -2.3M | (0.0) | (0.0) | -776K | -3.1M | -3.1M | -3.1M | |
-16.3M | -8.9M | -6.4M | -13.6M | -7.4M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | -6.6M | -7.5M | -2.5M | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) | |
-1.3M | -1M | -385K | -1.1M | -2.2M | 472K | -63K | -11K | -347K | 0.0 | 6.6M | 49.9M | 5M | 378K | 398K | 132K | 0.0 | 0.0 | 246K | 766K | |
-17.6M | -9.9M | -8M | -16.2M | -31.7M | 3.9M | -63K | -12.2M | 1.6M | -286K | -7.6M | -5.1M | -21.3M | -3.1M | 9.6M | 132K | -776K | -3.1M | -1.6M | -9.3M | |
CASH FLOW SUMMARY | ||||||||||||||||||||
4.1M | -2.1M | -451K | -3M | -2.2M | 1.8M | -389K | -2.1M | 1.7M | -735K | -1.3M | -980K | -1.5M | -257K | -452K | 1.7M | 831K | -1.4M | 711K | 196K | |
9.2M | 2.3M | 22.3M | -26.2M | -5.9M | 38.4M | 3M | 7.7M | 10.6M | -9.1M | -17.3M | -18.5M | -2M | 20.3M | 11.4M | 12.1M | 685K | -10.4M | 6.2M | 1.2M | |
84.7M | 82.4M | 60M | 86.2M | 92.1M | 53.6M | 50.6M | 42.9M | 32.3M | 41.4M | 58.7M | 77.2M | 79.2M | 59M | 47.6M | 35.5M | 34.9M | 45.3M | 39.1M | 37.9M | |
93.9M | 84.7M | 82.4M | 60M | 86.2M | 92.1M | 53.6M | 50.6M | 42.9M | 32.3M | 41.4M | 58.7M | 77.2M | 79.2M | 59M | 47.6M | 35.5M | 34.9M | 45.3M | 39.1M | |
28.8M | 14.3M | 30.7M | -6.9M | 27.9M | 32.8M | 3.4M | 17M | 5M | -8.1M | -12.4M | -12.1M | 20.8M | 20M | 1.5M | 13.6M | -2.3M | -6.7M | 7.4M | 10.8M |
NATR - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
8-K 8-K 2026 N/A | May 11, 2026 | May 11, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 07, 2026 | May 07, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 07, 2026 | March 31, 2026 | 2026 | |
DEF 14A DEF 14A 2026 N/A | March 27, 2026 | March 27, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 10, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 10, 2026 | March 10, 2026 | 2026 | |
10-Q 10-Q 2025 Q3 Q3 | November 06, 2025 | September 30, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 06, 2025 | November 06, 2025 | 2025 | |
8-K 8-K 2025 N/A | October 15, 2025 | October 10, 2025 | 2025 | |
8-K 8-K 2025 N/A | July 31, 2025 | July 31, 2025 | 2025 |
Continue your NATR research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.